Radisens has a business to business commercial approach with the aim to develop strategic partnerships. These include technology licensing, manufacture and distribution relationships with collaborators in the monitoring of iron stores within blood donor clinics or related markets. In addition, the Gemini™ platform is expandable for the measurement of analytes other than those in development by Radisens.
Radisens is leading a €7 million grant-aided FerrTest consortium, including Trinity College Dublin, Irish Manufacturing Research and PolyPico Technologies, to complete product & process development and scale-up ahead of pre-clinical trials. Radisens seeks partner(s) to commence this project and support commercialisation of the Gemini™ Ferritin test.